DNA construction firm Gen9 and British synthetic biology network SynbiCite have announced a partnership to increase access to gene synthesis technology.

Children's Hospital Los Angeles and Thermo Fisher Scientific announced today that they will partner to develop a next-generation sequencing-based gene panel for pediatric cancer research.

4.1 General requirements 4.1.1 The organizationshall document a quality management system and maintain its effectiveness in accordancewith the requirements of this International Standard and applicable regulatoryrequirements.

Christian Millare had a severe seizure on Jan. 5, 2008, and died. He was two years old. His mother Amy Williams is convinced, based on his medical records, the opinions of experts, and the published literature,

Recently, WuXi AppTec and Huawei have signed a strategic cloud cooperation agreement in precision medical in Shenzhen.

As part of his proposed 2016 federal budget, Canadian Prime Minister Justin Trudeau has called for C$237.2 million ($180.4 million)

R-Biopharm said today it will partner with Merck KGaA to develop companion diagnostics through a collaboration.

Roche announced today that the US Food and Drug Administration has approved the use of Roche's Cobas Zika assay to screen blood samples under an Investigational New Drug application protocol.

Luxembourg's Advanced Biological Laboratories (ABL) announced recently that it has signed an agreement granting Thermo Fisher Scientific international distribution rights

Blueprint Medicines is collaborating with Roche on the discovery, development and commercialisation of up to five targeted cancer immunotherapies, in a deal potentially worth more than $1 billion.

Affymetrix's board of directors today dismissed the most recent bid by Origin Technologies to acquire Affy for $17.00 per share in an all-cash transaction,

Recently, AES (Advanced Electrophoresis Solutions Ltd.) located in Cambridge, Canada announced that Ms. Mu Yiping will become the executive director & co-CEO

According to GEN website, Regeneron Pharmaceuticals recently had granted Intellia Therapeutics gene editing technology.

Today, GE Ventures and Mayo Clinic announced the launch of Vitruvian Networks, Inc., an independent platform company committed to accelerating

Life science company LGC announced today that it has acquired a majority stake in laboratory automation company Douglas Scientific.